<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02770768</url>
  </required_header>
  <id_info>
    <org_study_id>IRB16-0087</org_study_id>
    <nct_id>NCT02770768</nct_id>
  </id_info>
  <brief_title>Effects of Flibanserin on the Pre- and Post-menopausal Female Brain</brief_title>
  <official_title>Flibanserin and Women With Hypoactive Sexual Desire Disorder: A Double-Blind, Randomized, Electrical Neuroimaging Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Chicago</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the present study is to understand the neurobiological mechanisms of action
      underlying sexual desire building on prior work Dr. Stephanie Cacioppo has done in which
      desire was not manipulated. In the present project, Dr. Stephanie Cacioppo is manipulating
      desire through Flibanserin (Addyi) vs. placebo and she will be measuring subjective sexual
      desire as a manipulation check. The investigators will address this goal using a double-blind
      randomized outpatient design and determine the pre-post neurobehavioral change in the
      Flibanserin group and investigate the extent to which Flibanserin normalizes brain activity
      in premenopausal women with HSDD and the extent to which regional brain activation is
      associated with changes in symptoms and behavior (as measured with self-report measures of
      sexual desire and/or eye-tracking movements).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypoactive sexual desire disorder (HSDD) is the most common sexual complaint in women. Over
      the past 8 years, Dr. Stephanie Cacioppo has developed and validated the Desire Intention
      task, in which individuals are instructed to indicate as rapidly and as accurately as
      possible whether or not each visually presented stimulus (e.g., attractive persons of the
      opposite sex) is sexually desirable to them at the moment of the experiment. Flibanserin
      (Addyi) is a new medication approved by the FDA for the treatment of HSDD in pre-menopausal
      women. The investigators propose a study using the DIT to determine the extent to which
      Flibanserin normalizes brain activity in women with HSDD and the extent to which regional
      brain activation is associated with changes in symptoms and behavior.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>EEG Results: Evoked Brain Potentials (measured brain response that is the direct result of a specific cognitive event)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Change from baseline EEG results at 8 weeks. Average the electrical brain activity evoked by each type of stimuli to calculate the evoked brain potentials (any stereotyped electrophysical response to a stimulus).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Eye movement tracking: movements to first saccades</measure>
    <time_frame>8 weeks</time_frame>
    <description>Change from baseline eye movement tracking results at 8 weeks.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hypoactive Sexual Desire Disorder</condition>
  <arm_group>
    <arm_group_label>Flibanserin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drug: Flibanserin
8 weeks
100mg once daily at bedtime</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Drug: Matching Placebo Matching placebo capsules taken in same amount of pills as the active medication (for 8 weeks once daily at bedtime)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Flibanserin</intervention_name>
    <description>Observational study using electroencephalogram (EEG) and eye movement tracking device at baseline, week 4, and week 8 while subjects are taking either Flibanserin or matching placebo.</description>
    <arm_group_label>Flibanserin</arm_group_label>
    <other_name>Addyi</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Observational study using electroencephalogram (EEG) and eye movement tracking device at baseline, week 4, and week 8 while subjects are taking either Flibanserin or matching placebo.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Matching placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female

          -  Ages 21-45 or 51-74

          -  Pre- or Postmenopausal

          -  DSM-5 diagnosis of hypoactive sexual desire disorder (HSDD)

          -  Right-handed

        Exclusion Criteria:

          -  Male

          -  Pregnant women

          -  Nursing women

          -  Post-menopausal women

          -  Women who report not being able to stop drinking alcohol during the duration of the
             study

          -  Currently taking psychotropic medication

          -  History of seizures or neurological disorders

          -  Under hormonal therapy

          -  Current or past diagnosis of cancer

          -  Any unstable medical illnesses

          -  Lifetime history of bipolar disorder, schizophrenia, or psychotic disorder

          -  Current or recent (past 3 months) substance abuse or dependence

          -  Current or recent (past 3 months) clinical depression

          -  Currently taking any medications that have/may have unfavorable interactions with
             Flibanserin
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephanie Cacioppo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chicago</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jon E Grant, MD, JD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chicago</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Redden</last_name>
    <phone>773-702-9066</phone>
    <email>sredden@uchicago.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Redden, BA</last_name>
      <phone>773-702-9066</phone>
      <email>sredden@uchicago.edu</email>
    </contact>
    <contact_backup>
      <last_name>Stephanie Cacioppo, PhD</last_name>
      <phone>773-702-6983</phone>
      <email>scacioppo@yoda.bsd.uchicago.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Stephanie Cacioppo, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jon E Grant, JD, MD, MPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Royce Lee, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bianchi-Demicheli F, Cojan Y, Waber L, Recordon N, Vuilleumier P, Ortigue S. Neural bases of hypoactive sexual desire disorder in women: an event-related FMRI study. J Sex Med. 2011 Sep;8(9):2546-59. doi: 10.1111/j.1743-6109.2011.02376.x. Epub 2011 Jun 30.</citation>
    <PMID>21718449</PMID>
  </reference>
  <reference>
    <citation>Bolmont M, Cacioppo JT, Cacioppo S. Love is in the gaze: an eye-tracking study of love and sexual desire. Psychol Sci. 2014 Sep;25(9):1748-56. doi: 10.1177/0956797614539706. Epub 2014 Jul 16.</citation>
    <PMID>25031302</PMID>
  </reference>
  <reference>
    <citation>Cacioppo S, Bianchi-Demicheli F, Frum C, Pfaus JG, Lewis JW. The common neural bases between sexual desire and love: a multilevel kernel density fMRI analysis. J Sex Med. 2012 Apr;9(4):1048-54. doi: 10.1111/j.1743-6109.2012.02651.x. Epub 2012 Feb 21.</citation>
    <PMID>22353205</PMID>
  </reference>
  <reference>
    <citation>Cacioppo S, Cacioppo JT. Dynamic spatiotemporal brain analyses using high-performance electrical neuroimaging, Part II: A step-by-step tutorial. J Neurosci Methods. 2015 Dec 30;256:184-97. doi: 10.1016/j.jneumeth.2015.09.004. Epub 2015 Sep 10.</citation>
    <PMID>26363189</PMID>
  </reference>
  <reference>
    <citation>Cacioppo S, Couto B, Bolmont M, Sedeno L, Frum C, Lewis JW, Manes F, Ibanez A, Cacioppo JT. Selective decision-making deficit in love following damage to the anterior insula. Curr Trends Neurol. 2013;7:15-19.</citation>
    <PMID>25382944</PMID>
  </reference>
  <reference>
    <citation>Cacioppo S, Weiss RM, Runesha HB, Cacioppo JT. Dynamic spatiotemporal brain analyses using high performance electrical neuroimaging: theoretical framework and validation. J Neurosci Methods. 2014 Dec 30;238:11-34. doi: 10.1016/j.jneumeth.2014.09.009. Epub 2014 Sep 20.</citation>
    <PMID>25244954</PMID>
  </reference>
  <reference>
    <citation>Ortigue S, Bianchi-Demicheli F. The chronoarchitecture of human sexual desire: a high-density electrical mapping study. Neuroimage. 2008 Nov 1;43(2):337-45. doi: 10.1016/j.neuroimage.2008.07.059. Epub 2008 Aug 13.</citation>
    <PMID>18761412</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 22, 2016</study_first_submitted>
  <study_first_submitted_qc>May 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2016</study_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HSDD (Hypoactive Sexual Desire Disorder)</keyword>
  <keyword>EEG (Electroencephalogram)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypokinesia</mesh_term>
    <mesh_term>Sexual Dysfunctions, Psychological</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

